×

Cartridge device with fluidic junctions for coagulation assays in fluid samples

  • US 10,048,282 B2
  • Filed: 09/25/2015
  • Issued: 08/14/2018
  • Est. Priority Date: 09/26/2014
  • Status: Active Grant
First Claim
Patent Images

1. A sample analysis cartridge comprising:

  • an inlet chamber configured to receive a biological sample;

    a conduit fluidically connected to the inlet chamber and configured to receive the biological sample from the inlet chamber, the conduit splitting at a first junction into a first conduit and a second conduit configured to split the biological sample into at least first and second segments;

    the first conduit fluidically connected to the conduit at the first junction and configured to receive the first segment of the biological sample, the first conduit comprising a first reagent, a first sensor region comprising a first sensor, and a first fluidic lock valve downstream of the first sensor region;

    the second conduit fluidically connected to the first conduit at the first junction and configured to receive the second segment of the biological sample, the second conduit comprising a second reagent, a second sensor region comprising a second sensor, and a second fluidic lock valve downstream of the second sensor region;

    wherein the second conduit further comprises a flow restrictor downstream of the first junction and upstream of the second sensor region, configured to cause the biological sample to preferential enter the first conduit and form the first segment of the biological sample; and

    an air bladder connected to the inlet chamber and forming a part of a pump configured, during operation;

    to displace fluids within conduits of the sample analysis cartridge;

    to push the first segment of the biological sample over the first sensor region to the first fluidic lock valve, such that the first segment of the biological sample is locked within the first conduit; and

    to push the second segment of the biological sample over the second sensor region to the second fluidic lock valve, such that the second segment of the biological sample is locked within the second conduit;

    wherein the first sensor region comprises at least one prothrombin time sensor, and the second sensor region comprises at least one activated partial thromboplastin time sensor;

    wherein the first reagent comprises a first thrombin-cleavable peptide with a detectable moiety, and the second reagent comprises a second thrombin-cleavable peptide with a detectable moiety; and

    wherein the first reagent is different from the second reagent.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×